知名基金经理，转行当上A股董秘！

Core Viewpoint - The trend of fund managers transitioning to roles as company secretaries in listed firms is increasing, indicating a shift beyond traditional asset management roles [2][6]. Group 1: Fund Manager Transition - More fund managers are being appointed as company secretaries in listed companies, a trend that has been observed since 2024 [2][6]. - The case of Jiang Ying, a former fund manager at Guotai Fund, being appointed as the secretary of Luoxin Pharmaceutical highlights this trend [3][6]. - Jiang Ying has a strong academic background with degrees from Peking University and the University of Hong Kong, but lacks prior experience as a company secretary [3][6]. Group 2: Company Performance - Luoxin Pharmaceutical, founded in 1988, has a diverse product range covering various medical fields, but has faced significant performance fluctuations in recent years [6]. - The company reported a revenue of 1.077 billion yuan for the first half of 2025, a decrease of 14.45% year-on-year, while achieving a net profit of 17.695 million yuan, marking a return to profitability [6][7]. - The financial performance of Luoxin Pharmaceutical has been impacted by factors such as the COVID-19 pandemic and adjustments in financial liabilities [6][7]. Group 3: Broader Industry Trends - The trend of financial professionals moving into corporate roles is not limited to fund managers; there are also instances of analysts and investment bankers transitioning to company secretary positions [8][9]. - The hiring of former fund managers for roles in research and development within companies, such as Liu Haoyu at Donghua Energy, indicates a diversification of career paths for financial professionals [9].